Capital World Investors Intercept Pharmaceuticals, Inc. Transaction History

Capital World Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $8.33 Million - $11.4 Million	-213,137 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$60.0 - $85.67 $61.9 Million - $88.4 Million	-1,031,622 Reduced 82.88%	213,137 $17.9 Million
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $4.27 Million - $5.45 Million	81,000 Added 6.96%	1,244,759 $76.6 Million
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $40.2 Million - $50.2 Million	-690,200 Reduced 37.23%	1,163,759 $68 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $106 Million - $220 Million	1,853,959	1,853,959 $108 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.